Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?

The Invesco Pharmaceuticals ETF (PJP) was launched on June 23, 2005, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Pharma segment of the equity market.

Zacks Investment Research • Feb 23, 2026

Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?

The Invesco Pharmaceuticals ETF (PJP) was launched on 06/23/2005, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.

Zacks Investment Research • Jan 13, 2026

Healthcare Dashboard For December And Focus On PJP

Healthcare providers and pharmaceuticals are the most compelling subsectors based on value and quality scores. PJP delivers attractive historical risk-adjusted returns compared to XLV and XPH. 10 healthcare stocks cheaper than their peers in December.

Seeking Alpha • Dec 14, 2025

Pharma ETFs to Gain From Landmark UK-US Zero-Tariff Deal

Pharma ETFs like IHE are poised to surge as the UK-US zero-tariff deal raises UK drug prices and strengthens major U.S. players' outlook.

Zacks Investment Research • Dec 9, 2025

Ozempic—and 14 other popular prescription drugs—will cost less for Medicare after the U.S. government negotiated lower prices

The price cuts will save Medicare billions of dollars in prescription-drug spending.

WSJ • Nov 25, 2025

Investing In Health Stocks - How Policy Clarity Is Opening Doors

The healthcare sector has experienced one of its most significant de-ratings in 35 years, with valuations now at a 30% discount to the broader market. Healthcare trades at historical valuation discounts across multiple metrics.

Seeking Alpha • Nov 11, 2025

4 Reasons to Buy Pharma ETFs Now for a Healthy Portfolio

Pharma's Trump-Pfizer boost sparks momentum, making ETFs PPH, IHE, PJP & XPH attractive for defensive, undervalued growth plays.

Zacks Investment Research • Oct 6, 2025

Pharma stocks gain, as Trump's tariff move actually could be a win for the sector

Pharmaceutical stocks mostly gained Friday, as traders appeared to shrug off or even cheer President Donald Trump's rollout of a new tariff plan for drugmakers.

Market Watch • Sep 26, 2025

Big Pharma Unfazed by Trump Tariffs, But Small Biotechs Face Vulnerability

Drugmakers have been bracing for levies and sought to get ahead of them with pledges to invest billions more on domestic manufacturing.

WSJ • Sep 26, 2025

PJP: Healthcare Dashboard For August

This article provides a top-down view of the healthcare sector based on valuation, quality and momentum. The healthcare providers and pharmaceuticals/biotechnology subsectors show good value scores. The Invesco Pharmaceuticals ETF has outperformed the pharma industry benchmark XPH and the broader healthcare ETF XLV since 2006.

Seeking Alpha • Aug 18, 2025